VERTEX PHARMACEUTICALS INC
VRTXNASDAQ🏆 #111 by market capEarnings Nov 2Biotech
$529.65▲ $5.83 (+1.10%)
Market closed · at close1h—
24h▲ 1.1%
7d▲ 9.3%
14d▲ 9.5%
30d▲ 10.3%
1y▲ 36.5%
🏦Market Cap
$134.43B
Mid Cap
📈Revenue Growth (YoY)
+10.2%
Healthy
📊Gross Margin
86.0%
High
💵FCF Margin
29.5%
Strong
⚖️P/S Ratio
10.1x
Elevated
Otter Score
52
Weak
📊
Analyst Ratings
Price
$529.65
Total
56
Raised
9
Lowered
2
Avg PT
$559.33
| Institution | Action | Rating | Date |
|---|---|---|---|
Barclays | Reiterated | Overweight | 2026-08-05 |
Truist Securities | Reiterated | Buy | 2026-08-05 |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-04 |
TD Cowen | Reiterated | Buy | 2026-08-04 |
Canaccord Genuity | Reiterated | Hold | 2026-08-04 |
UBS | Reiterated | Buy | 2026-07-13 |
RBC Capital | Reiterated | Outperform | 2026-07-07 |
Baird | Reiterated | Underperform | 2026-07-07 |
Morgan Stanley | Reiterated | Overweight | 2026-05-05 |
Bernstein | Reiterated | Outperform | 2026-05-05 |
Maxim Group | Upgraded | Hold → Buy | 2026-03-18 |
Citigroup | Reiterated | Buy | 2026-03-10 |
B of A Securities | Reiterated | Buy | 2026-03-10 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-10 |
Oppenheimer | Reiterated | Outperform | 2026-03-10 |
HC Wainwright& Co. | Reiterated | Buy | 2026-02-17 |
Stifel | Reiterated | Hold | 2026-02-13 |
Scotiabank | Reiterated | Sector Perform | 2026-02-13 |
Evercore ISI Group | Reiterated | Outperform | 2026-01-23 |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-01-06 |
Leerink Partners | Reiterated | Outperform | 2025-12-29 |
Wells Fargo | Reiterated | Overweight | 2025-12-10 |
JP Morgan | Reiterated | Overweight | 2025-10-08 |
Guggenheim | Reiterated | Buy | 2025-08-06 |
BMO Capital | Reiterated | Outperform | 2025-08-05 |
Needham | Reiterated | Hold | 2025-05-06 |
Piper Sandler | Reiterated | Overweight | 2025-01-27 |
Jefferies | Upgraded | Hold → Buy | 2024-12-09 |
Argus Research | Reiterated | Buy | 2024-06-17 |
Goldman Sachs | Reiterated | Buy | 2024-01-31 |
William Blair | Reiterated | Outperform | 2023-05-30 |
SVB Leerink | Reiterated | Outperform | 2023-02-08 |
Cowen & Co. | Reiterated | Outperform | 2022-06-13 |
Raymond James | Reiterated | Market Perform → Perform | 2021-07-01 |
Credit Suisse | Reiterated | Outperform | 2021-02-02 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-06-24 |
CFRA | Reiterated | Buy | 2020-04-30 |
JMP Securities | Reiterated | Market Outperform | 2020-04-30 |
Stifel Nicolaus | Reiterated | Buy | 2020-01-31 |
PiperJaffray | Reiterated | Overweight | 2020-01-06 |
Bank of America | Reiterated | Buy | 2019-11-20 |
Piper Jaffray | Reiterated | Overweight | 2019-10-31 |
H.C. Wainwright | Upgraded | Neutral → Buy | 2018-10-26 |
Argus | Upgraded | Hold → Buy | 2018-05-05 |
Deutsche Bank | Reiterated | Buy | 2017-12-13 |
DA Davidson | Reiterated | Buy | 2017-09-29 |
Janney Montgomery Scott | Upgraded | Neutral → Buy | 2017-07-19 |
Janney Capital | Upgraded | Neutral → Buy | 2017-07-19 |
Leerink Swann | Reiterated | Outperform | 2016-03-08 |
BTIG Research | Reiterated | Buy | 2015-01-06 |
Summer Street | Downgraded | Buy → Neutral | 2013-10-30 |
Wunderlich | Reiterated | Buy | 2013-05-17 |
Lazard | Downgraded | Buy → Neutral | 2013-01-15 |
Brean Capital | Upgraded | Hold → Buy | 2012-05-08 |
ISI Group | Upgraded | Neutral → Buy | 2012-05-07 |
Bank oferica | Reiterated | Buy | 2012-03-14 |
One row per institution, most recent rating